Grenada vs India: Hepatitis B surface antigen (HBsAg) prevalence
Grenada
0.2%
in 2024
India
0.2%
in 2024
Grenada rank
82nd
India rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Grenada
- India
How they compare
Grenada currently reports 0.2% against 0.2% in India, a difference of 0.0%.
Across all 10 years both countries report, India has been ahead every year.
Grenada ranks 82nd and India ranks 82nd of 194 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Grenada | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | India |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Grenada or India?
- Grenada, at 0.2% against 0.2% in India as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Grenada and India?
- 0.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and India?
- 10 years are reported by both, from 2015 to 2024.
- How do Grenada and India rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Grenada ranks 82nd and India ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.